Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Cencora (COR) stock in plain English

Free brief · no signupStart here
CORPublished Nov 14, 2026
Cencora Inc
Healthcare · Medical Distribution
Distributes prescription drugs, specialty medicines, and healthcare products to pharmacies and health systems worldwide.
Assets:
Over 150 distribution centersoperates automated facilities globally across 50 countries
46,000 employeesstaffs logistics, commercial consulting, and specialty care teams
Alliance Healthcare networkdelivers medicines to thousands of European pharmacies daily
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

36
OPS ScoreOperating finances
Latest quote
-2.03%$341.25
$65.12B
19.1×
$342.74B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 14, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was COR. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Cencora (COR) do?

Cencora Inc (COR) is a U.S.-listed company in Healthcare (Medical Distribution). What it does: Distributes prescription drugs, specialty medicines, and healthcare products to pharmacies and health systems worldwide. It purchases and delivers pharmaceuticals to hospitals, pharmacies, and clinics across global distribution networks. It is worth $65.12B on the market and sold $342.74B over the last year.

Market cap
$65.12B
P/E ratio
19.1×
Annual sales
$342.74B
Sector
Healthcare
Industry
Medical Distribution
Brief updated
Nov 14, 2026

Brands and businesses behind COR

  • Alliance Healthcare: It distributes pharmaceutical products to independent pharmacies and hospitals across Europe, earning fees on wholesale deliveries.
  • World Courier: It provides temperature-controlled logistics for clinical trials and biopharma products, charging fees for specialized shipping and storage.
  • Good Neighbor Pharmacy: It operates an independent pharmacy franchise network, earning membership fees and wholesale supply revenue from member stores.
  • MWI Animal Health: It supplies animal health pharmaceuticals and supplies to veterinary practices and livestock producers, earning wholesale distribution revenue.

COR’s flags, in plain English

Each flag is a number from Cencora’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 14, 2026.

Earns Its Keep

Earns 134.3% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.

Capital Works Hard

Earns 23.6% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.

Still Climbing

Sales up 9.5% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Debt Is Driving

Heavy debt, 306% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.

1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about COR

How big is Cencora?

Cencora’s market cap is $65.12B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $342.74B: what customers paid the company over the last year, before any costs.

What is COR’s P/E ratio?

COR’s P/E ratio is 19.1×. Investors pay about 19.1 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with COR?

A single customer, Walgreens Boots Alliance, accounts for over ten percent of total company revenues. That is one risk on Cencora’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Cencora’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. COR’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card